Impact BioMedical Inc. (IBO)
NYSEAMERICAN: IBO · Real-Time Price · USD
0.660
0.00 (0.00%)
At close: Apr 28, 2026, 4:00 PM EDT
0.652
-0.008 (-1.21%)
Pre-market: Apr 29, 2026, 7:17 AM EDT
Impact BioMedical Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -11.84 | -24.71 | -4.34 | -7.05 | -1.3 | |
| Depreciation & Amortization | 1.15 | 0.01 | 0.01 | - | - | |
| Other Amortization | - | 1.11 | 1.11 | 1.11 | 1.11 | |
| Loss (Gain) From Sale of Assets | 0.01 | - | - | - | - | |
| Asset Writedown & Restructuring Costs | - | 25.36 | - | - | - | |
| Loss (Gain) From Sale of Investments | - | - | - | 4.1 | - | |
| Stock-Based Compensation | 0.2 | 0.02 | - | - | - | |
| Other Operating Activities | 7.99 | -4.03 | -0.07 | -0.83 | -1.94 | |
| Change in Accounts Receivable | -0 | 0.13 | -0.13 | - | - | |
| Change in Inventory | 0.01 | - | - | - | - | |
| Change in Accounts Payable | 0.47 | -0.44 | 0.29 | 0.42 | 0.11 | |
| Change in Other Net Operating Assets | 0.12 | -0.3 | 0.27 | -0 | -0 | |
| Operating Cash Flow | -1.89 | -2.85 | -2.85 | -2.24 | -2.03 | |
| Capital Expenditures | - | - | -0.02 | -0.28 | - | |
| Investment in Securities | - | - | - | -0.07 | -4.18 | |
| Other Investing Activities | 0 | 0 | 0 | -0.01 | -5.28 | |
| Investing Cash Flow | 0 | 0 | -0.02 | -0.35 | -9.46 | |
| Short-Term Debt Issued | 0.18 | 1.12 | - | 2.55 | 11.46 | |
| Long-Term Debt Issued | - | - | 2.87 | - | - | |
| Total Debt Issued | 0.18 | 1.12 | 2.87 | 2.55 | 11.46 | |
| Short-Term Debt Repaid | -0.29 | - | - | - | - | |
| Total Debt Repaid | -0.29 | - | - | - | - | |
| Net Debt Issued (Repaid) | -0.11 | 1.12 | 2.87 | 2.55 | 11.46 | |
| Issuance of Common Stock | - | 3.73 | - | - | - | |
| Financing Cash Flow | -0.11 | 4.85 | 2.87 | 2.55 | 11.46 | |
| Miscellaneous Cash Flow Adjustments | - | - | - | - | -0 | |
| Net Cash Flow | -2 | 2 | -0 | -0.04 | -0.03 | |
| Free Cash Flow | -1.89 | -2.85 | -2.87 | -2.52 | -2.03 | |
| Free Cash Flow Margin | -5906.25% | - | - | -5036.00% | - | |
| Free Cash Flow Per Share | -0.06 | -0.27 | -0.05 | -0.04 | -0.03 | |
| Levered Free Cash Flow | -1.52 | -1.92 | -1.44 | -0.98 | -1.16 | |
| Unlevered Free Cash Flow | -1.02 | -1.26 | -1.17 | -0.69 | -0.97 | |
| Change in Working Capital | 0.6 | -0.61 | 0.44 | 0.42 | 0.1 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.